The individually deferred dosing of G-CSF after autologous stem cell transplantation in patients with malignant lymphoma - results of multicentre randomised trial

被引：0
|
作者：
Faber, E
Pytlik, R
Trneny, M
Slaby, J
Kozak, T
Raida, L
Papalik, T
Zikesova, E
Zapletalova, J
Maresova, I
Hamouzova, M
Indrak, K
机构：
[1] Univ Hosp Olomouc, Olomouc, Czech Republic
[2] Univ Hosp Prague, Prague, Czech Republic
[3] Univ Hosp Vinohrady, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [21] A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation
    Grosso, Dolores
    Leiby, Benjamin
    Wilde, Lindsay
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    O'Hara, William
    Wagner, John L.
    Mateja, Gina
    Alpdogan, Onder
    Binder, Adam
    Kasner, Margaret
    Keiffer, Gina
    Klumpp, Thomas
    Martinez, Ubaldo Outschoorn
    Palmisiano, Neil
    Porcu, Pierluigi
    Gergis, Usama
    Flomenberg, Neal
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (12): : 831.e1 - 831.e7
  • [22] G-CSF AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT DISEASES IN CHILDREN
    MADERO, L
    MUNOZ, A
    DEHEREDIA, AD
    MARTINEZ, A
    BADELL, I
    ESQUEMBRE, C
    RAMIREZ, M
    OTHEO, E
    OLIVE, A
    SASTRE, A
    PARDO, N
    CASTELL, V
    BONE MARROW TRANSPLANTATION, 1995, 15 (03) : 349 - 351
  • [23] Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells (PBSCs) for autologous stem cell transplantation (ASCT) in patients with lymphoma.
    Mollee, PN
    Pereira, D
    Nagy, T
    Saragosa, R
    Keating, A
    Crump, M
    BLOOD, 2001, 98 (11) : 174A - 174A
  • [24] Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation
    P Cetkovský
    V Koza
    P Jindra
    P Škopek
    M Švojgrová
    Bone Marrow Transplantation, 1997, 20 : 639 - 641
  • [25] G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial
    Linch, DC
    Milligan, DW
    Winfield, DA
    Kelsey, SM
    Johnson, SA
    Littlewood, TJ
    Smith, GM
    Hutchinson, RM
    Goldstone, AH
    Fielding, AK
    Hudson, GV
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (04) : 933 - 938
  • [26] Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation
    Cetkovsky, P
    Koza, V
    Jindra, P
    Skopek, P
    Svojgrova, M
    BONE MARROW TRANSPLANTATION, 1997, 20 (08) : 639 - 641
  • [27] Administration of G-CSF after autologous peripheral stem cell transplantation is clinical and cost-effective
    Fruchart, C
    Journet, V
    Damourette, S
    Rivière, A
    German, O
    Musafiri, D
    Peny, AM
    BONE MARROW TRANSPLANTATION, 2004, 33 : S120 - S120
  • [28] Rituximab and autologous stem cell transplantation for malignant lymphoma after liver transplantation
    B Sánchez-González
    P Fernández-Abellán
    MC Garcia Garay
    B Villarrubia
    M F Palmero
    C Rivas
    Bone Marrow Transplantation, 2004, 33 : 1071 - 1072
  • [29] Rituximab and autologous stem cell transplantation for malignant lymphoma after liver transplantation
    Sánchez-González, B
    Fernández-Abellán, P
    Garay, MC
    Villarrubia, B
    Palmero, MF
    Rivas, C
    BONE MARROW TRANSPLANTATION, 2004, 33 (10) : 1071 - 1072
  • [30] Hematopoietic, Immune Recovery and Outcomes after Autologous Stem Cell Transplantation Following Plerixafor Plus G-CSF Versus Chemotherapy and G-CSF Based Mobilization in Pediatric Patients
    Choi, Jung Yoon
    Kang, Hyoung Jin
    Hong, Kyung Taek
    Hong, Che Ry
    Park, Kyung Duk
    Shin, Hee Young
    BLOOD, 2017, 130
12345